Hong Guo Parke

Dr. Hong Guo Parke is a Research Fellow at Queen's University Belfast's Wellcome Wolfson Institute for Experimental Medicine, specializing in COPD pathogenesis and respiratory infections.

Research investigates airway epithelium senescence mechanisms, EBV suppression therapy for COPD management, and developmental aspects of pediatric airway immunity. Clinical trials include valaciclovir for viral suppression and icatibant for COVID-19.

Publications establish models for human airway epithelium studies, examining RSV responses across gestational ages. Research contributes to understanding epithelial-immune interactions in chronic respiratory diseases.